Send til en ven
RSS
google +
Printervenlig version

Nyheder (Sjældne sygdomme)

This section on health in the EU has been created as a trustworthy gateway to a wide range of information and data on health-related issues and activities at both European, national and international level. The content is produced by the European Commission, the Member States of the EU and the European Economic Area (EEA), plus EU candidate countries; by international organisations; and by pan-European non-governmental organisations in the area of public health.

European Medicines Agency recommends approval of a locally targeted treatment for ulcerative colitis and Crohn’s disease    europa.eu

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorisation for Entyvio (vedolizumab) for the treatment of adult patients [...]

Joint EMA/FDA/MHLW-PMDA orphan medicinal product workshop takes place today    europa.eu

A workshop on orphan product designation and grants is taking place today at the European Medicines Agency (EMA), jointly organised by the EMA, the US Food and Drug Administration (FDA) and for the f[...]

Safe treatment for AK, a rare eye disease    europa.eu

The ODAK ('Orphan Drug for Acanthamoeba Keratitis') project is working to develop a safe and effective treatment for Acanthamoeba keratitis (AK), a rare infectious eye disease which causes severe deb[...]

Health-EU Newsletter: Rare Disease Day 2014: Joining together across Europe for better care    europa.eu

We are breaking the isolation and despair of children and adults who are amongst the most vulnerable citizens in our society today. By bringing together all 6000 different rare diseases across Europ[...]

Towards establishing a European platform on rare diseases registration    europa.eu

Rare Disease Day is observed internationally on the last day of February. Its global objective is to raise awareness for rare diseases and improve access to treatment and medical representation for i[...]

European Rare Diseases Day: Top facts on EU Action    europa.eu

European Commission - Press Release details page - Commission MEMO Brussels, 27 February 2014 European A disease or disorder is defined as rare in the EU when it affects less than five in every 10 0[...]

Rare Disease Day 2014 – twelve new orphan medicines available to patients over the past year    europa.eu

Over the past twelve months, a total of 12 medicines for the treatment of rare diseases were recommended for marketing authorisation by the European Medicines Agency's (EMA) Committee for Medicinal P[...]

First meeting of the Expert Group on Rare Diseases: 11-12 February 2014    europa.eu

Directorate General for Health & Consumers[...]

Events - 6th Familial Cancer Conference (ESO-CNIO) - 5-6 June 2014, Madrid, Spain    europa.eu

Main Topics: General concepts in familial cancer; genetic variants and familial cancer; genetic counseling * Common cancers: The family of breast cancer genes; selection criteria and clinical man[...]

Registration opens for joint EMA/FDA/MHLW-PMDA orphan medicinal product workshop    europa.eu

Registration is open for the third workshop on orphan product designation and grants jointly organised by the European Medicines Agency (EMA), the US Food and Drug Administration (FDA) and, for the f[...]

European Medicines Agency applies greater fee-reduction rates for orphan medicines in 2014    europa.eu

The European Medicines Agency's policy on fee reductions for orphan medicinal products has been revised.[...]

Disclaimer

The European Commission is solely responsible for information present on EU-level websites, information present in the Portal originated by the Commission. National-level information is provided by the Member States concerned and Member States are solely responsible for the accuracy of the information. Likewise, the European Commission is not responsible for information on non-governmental organisations and international organisations websites. The European Union is committed to user privacy. Read more concerning the Legal Notice.
Further questions can be answered through the Contact page. The Health-EU portal supports principles and measures to increase the credibility of information on the net. It complies with the HONcode standard for trustworthy health information: verify here.